liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
KTH, Science for Life Laboratory, SciLifeLab, Sweden.ORCID iD: 0000-0002-7422-6104
KTH, Science for Life Laboratory, SciLifeLab, Sweden.ORCID iD: 0000-0002-2851-9651
KTH, Science for Life Laboratory, SciLifeLab, Sweden.ORCID iD: 0000-0003-2261-0881
KTH, Science for Life Laboratory, SciLifeLab, Sweden.ORCID iD: 0000-0002-0017-7987
Show others and affiliations
2021 (English)In: EBioMedicine, E-ISSN 2352-3964, Vol. 74, p. 103723-, article id 103723Article in journal (Refereed) Published
Abstract [en]

Background: COVID-19 has caused millions of deaths globally, yet the cellular mechanisms underlying the various effects of the disease remain poorly understood. Recently, a new analytical platform for comprehensive analysis of plasma protein profiles using proximity extension assays combined with next generation sequencing has been developed, which allows for multiple proteins to be analyzed simultaneously without sacrifice on accuracy or sensitivity. Methods: We analyzed the plasma protein profiles of COVID-19 patients (n = 50) with mild and moderate symptoms by comparing the protein levels in newly diagnosed patients with the protein levels in the same individuals after 14 days. Findings: The study has identified more than 200 proteins that are significantly elevated during infection and many of these are related to cytokine response and other immune-related functions. In addition, several other proteins are shown to be elevated, including SCARB2, a host cell receptor protein involved in virus entry. A comparison with the plasma protein response in patients with severe symptoms shows a highly similar pattern, but with some interesting differences. Interpretation: The study presented here demonstrates the usefulness of "next generation plasma protein profiling" to identify molecular signatures of importance for disease progression and to allow monitoring of disease during recovery from the infection. The results will facilitate further studies to understand the molecular mechanism of the immune-related response of the SARS-CoV-2 virus. (C) 2021 The Author(s). Published by Elsevier B.V.

Place, publisher, year, edition, pages
Elsevier BV , 2021. Vol. 74, p. 103723-, article id 103723
Keywords [en]
COVID-19, Protein profiling, Plasma proteome, Immune response
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-189622DOI: 10.1016/j.ebiom.2021.103723ISI: 000730209800003PubMedID: 34844191Scopus ID: 2-s2.0-85120360723OAI: oai:DiVA.org:liu-189622DiVA, id: diva2:1707173
Available from: 2022-01-19 Created: 2022-10-30

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopusFulltext

Authority records

Zhong, WenAltay, ÖzlemArif, MuhammadEdfors, FredrikMardinoglu, AdilUhlén, MathiasFagerberg, Linn

Search in DiVA

By author/editor
Zhong, WenAltay, ÖzlemArif, MuhammadEdfors, FredrikMardinoglu, AdilUhlén, MathiasFagerberg, Linn
In the same journal
EBioMedicine
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 83 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf